Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Debt / NOTE 0.625% 4/0
-
Market price (% of par)
-
97.6%
-
Total 13F principal
-
$373,094,912
-
Principal change
-
+$202,006,912
-
Total reported market value
-
$366,446,586
-
Number of holders
-
35
-
Value change
-
+$199,449,681
-
Number of buys
-
30
-
Number of sells
-
5
Institutional Holders of SUPERNUS PHARMACEUTICALS INC - NOTE 0.625% 4/0 as of Q2 2019
As of 30 Jun 2019 SUPERNUS PHARMACEUTICALS INC - NOTE 0.625% 4/0 had 35 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of $373,094,912 principal (par value or face value) of the bond of the company.
Largest 10 bondholders included ADVENT CAPITAL MANAGEMENT /DE/, Allianz Asset Management GmbH, PRUDENTIAL PLC, NN Investment Partners Holdings N.V., JPMORGAN CHASE & CO, ZAZOVE ASSOCIATES LLC, CALAMOS ADVISORS LLC, MACKAY SHIELDS LLC, STATE STREET CORP, and Invesco Ltd..
This table shows 35 bond principal holders of the security as of 30 Jun 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.